Efficacy and Safety of azithromycin 1.5% eye drops (Azyter®) in patients with moderate to severe chronic blepharitis.

被引：0
|
作者：
Doan, Serge [1 ,2 ]
Baudouin, Christophe [3 ]
Labetoulle, Marc [4 ]
Bourcier, Tristan [5 ]
Hoffart, Louis [6 ]
Pisella, Pierre-Jean [7 ]
机构：
[1] Hop Xavier Bichat, Ophthalmol, Paris, France
[2] A de Rothschild Fdn, Paris, France
[3] Quinze Vingts Natl Ophthalmol Hosp, Ophthalmol, Paris, France
[4] Bicetre Univ Hosp, Ophthalmol, Le Kremlin Bicetre, France
[5] Univ Hosp Strasbourg, Ophthalmol, Strasbourg, France
[6] Timone Univ Hosp, Ophthalmol, Marseille, France
[7] Univ Hosp Tours, Ophthalmol, Tours, France
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2014年 / 55卷 / 13期
关键词：
526; eyelid; 422; antibiotics/antifungals/antiparasitics;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
47
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of reslizumab in patients with moderate to severe eosinophilic asthma
    Lim, Hui Fang
    Nair, Parameswaran
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2015, 9 (02) : 135 - 142
  • [22] Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma
    Wechsler, Michael E.
    Ruddy, Marcella K.
    Pavord, Ian D.
    Israel, Elliot
    Rabe, Klaus F.
    Ford, Linda B.
    Maspero, Jorge F.
    Abdulai, Raolat M.
    Hu, Chih-Chi
    Martincova, Renata
    Jessel, Andreas
    Nivens, Michael C.
    Amin, Nikhil
    Weinreich, David M.
    Yancopoulos, George D.
    Goulaouic, Helene
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (18): : 1656 - 1668
  • [23] Evaluation of the efficacy and safety of a new device for eye drops instillation in patients with glaucoma
    Junqueira, Daniela M.
    Lopes, Flavio S.
    de Souza, Fabiola C.
    Dorairaj, Syril
    Prata, Tiago S.
    CLINICAL OPHTHALMOLOGY, 2015, 9 : 367 - 371
  • [24] EFFICACY AND SAFETY OF ELTROMBOPAG IN PATIENTS WITH MODERATE, SEVERE AND VERY SEVERE APLASTIC ANEMIA
    Nance, D.
    Rodgers, G.
    Nuttall, M.
    HAEMATOLOGICA, 2015, 100 : 299 - 299
  • [25] Adalimumab efficacy and safety results in patients with moderate to severe chronic plaque psoriasis: Subanalysis of patients with and without PsA
    Menter, MA
    Gordon, KB
    Leonardi, C
    Heffernan, MP
    Chen, DM
    RHEUMATOLOGY, 2005, 44 : I113 - I114
  • [26] Efficacy and safety of 0.3% carbomer gel compared to placebo in patients with moderate-to-severe dry eye syndrome
    Sullivan, LJ
    McCurrach, F
    Lee, S
    Taylor, HR
    Rolando, M
    MarechalCourtois, C
    CreuzotGarcher, C
    Karabatsas, C
    Hoh, MB
    Faschinger, C
    Laroche, L
    OPHTHALMOLOGY, 1997, 104 (09) : 1402 - 1408
  • [27] Safety of efalizumab in patients with moderate to severe chronic plaque psoriasis
    Leonardi, C
    Goffe, B
    Sobell, J
    Caro, I
    Wang, X
    Papp, K
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) : A58 - A58
  • [28] Efficacy and safety of using topical cyclosporine A for treatment of moderate to severe dry eye disease
    Othman, Tageldin M.
    Mousa, Ahmed
    Gikandi, Priscilla W.
    AbdelMabod, Mohamed
    Abdelrahman, Ahmed M.
    SAUDI JOURNAL OF OPHTHALMOLOGY, 2018, 32 (03) : 217 - 221
  • [29] Efficacy and safety of briakinumab vs. etanercept and placebo in patients with moderate to severe chronic plaque psoriasis
    Gottlieb, A. B.
    Leonardi, C.
    Kerdel, F.
    Mehlis, S.
    Olds, M.
    Williams, D. A.
    BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (03) : 652 - 660
  • [30] Adalimumab efficacy and safety results in patients with moderate to severe chronic plaque psoriasis with and without psoriatic arthritis
    Menter, MA
    Gordon, K
    Leonardi, C
    Chen, D
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P174 - P174
12345